Document is current
Any future updates will be listed below
-
Authors
González-Costello, José http://orcid.org/0000-0002-7437-3630
Comín-Colet, Josep
Lupón, Josep
Enjuanes, Cristina
de Antonio, Marta
Fuentes, Lara
Moliner-Borja, Pedro
Farré, Nuria
Zamora, Elisabet
Manito, Nicolás
Pujol, Ramón
Bayés-Genis, Antoni
-
Funding
Funding for this research was provided by:
Red de investigación Cardiovascular (RD12/0042/0047)
Instituto de Salud Carlos III (FIS PI14/01682)
- License Information
-
More Information
Article History
Received: 2 April 2018
Accepted: 19 October 2018
First Online: 1 November 2018
Ethics approval and consent to participate
: Written informed consent was obtained from each patient. The investigation conforms with the principles outlined in the Declaration of Helsinki. The local ethic committee from the Hospital Universitari de Bellvitge approved the study, ref.: PR088/16.
: Not applicable.
: JCC has received speaking fees from Vifor Pharma and was a member of the steering committee of the FAIR-HF and CONFIRM-HF studies. None of the other authors have any conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
